January 16, 2018 Gamida Cell Announces Initiation of a Phase I Study of NAM-NK Cells Immunotherapy Program for Non-Hodgkin Lymphoma and Multiple Myeloma View Article
January 8, 2018 Intec Pharma Announces Development Collaboration With Global Pharmaceutical Company View Article
January 4, 2018 Foamix Announces Positive Results from Phase 3 Open-Label Safety Extension Evaluating FMX-101 Topical Minocycline Foam for Treatment up to 1 Year View Article
December 13, 2017 The company is preparing for an IPO next year, after recently raising money at a $160 million company value. View Article
November 21, 2017 Gamida Cell Appoints Julian Adams, Ph.D., Chairman and Chief Executive Officer View Article
August 21, 2017 Gamida Cell Announces First Patient Transplanted in Phase 1/2 Study of CordIn for Severe Aplastic Anemia and Hypoplastic MDS View Article
